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of the literature
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Abstract
A 32-year-old woman presented with a slow-growing, painless, subcutaneous lesion in the right inguinal and
perineum regions. The mass was 24.0 cm× 10.5cm × 5.0cm in size, well circumscribed, mobile, and rubbery.
Microscopically, the resected mass was mainly composed by a proliferation of small spindle or stellate cells, variably
admixed with mature adipose tissue, embedded within an abundant myxoid and collagenized stroma.
Immunohistochemically, the spindle and stellate cells were strongly positive for vimentin, CD34, and bcl-2
antibodies but not for smooth muscle actin and desmin. The tumor was diagnosed as dendritic fibromyxolipoma
based on the typical findings of histology and immunohistochemistry. Clinical follow-up of 9 months after surgery
revealed no evidence of recurrence. We report the first case of dendritic fibromyxolipoma in the right inguinal and
perineum regions and discuss the different diagnosis.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1313680868103019.
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Introduction
Dendritic fibromyxolipoma (DFML) is a rare benign soft
tissue lesion that most commonly arises in the subcutis
or muscular fascia of the head and neck, shoulders, calf,
foot, or back in adult male patients. The characteristic
histologic picture is described as an admixture of mature
adipose tissue, spindle and stellate cells, and abundant
myxoid stroma with prominent collagenization. These
neoplasms typically show positive immunoreactivity for
CD-34, bcl-2 and Vimentim. We describe a case of DFML
in the right inguinal and perineum regions. To our best
knowledge, female DFML in inguinal including the
perineum region has not been reported.
Clinical summary
A 32-year-old woman was first seen by us 3 years after
becoming aware of a painless subcutaneous mass in her
right inguinal and perineum regions. Initially, the mass
was in the right inguinal region, grew up slowly towards
the perineum region. The mass was unreducible and
could not become more prominent when coughed,
strained, or stood up. The mass was grew fast with no ob-
vious incentive in the past three weeks. On physical exam-
ination, the mass was subcutaneous, 20cm×10cm×7cm
in size, mobile, rubbery, unreducible. The transillumin-
ation test and auscultation for bowel sounds on the mass
were negative. Her past and family histories were non-
contributory. Laboratory data as well as tumor markers,
such as CEA, CA19-9, were normal. Ultrasonography (US)
revealed a well circumscribed, inhomogeneous mass with
prominent vascularity, measuring about 19.7cm×9.2cm×
6.8cm, in the right inguinal and perineum regions. The
mass originated from the right labium majus pudendi and
extended to the low abdominal wall. No evidence was
shown for a connection between the abdominal cavity and
the mass. Also, computed tomography (CT) demonstrated
a mixed density, well circumscribed mass in the same
region. CT value of the mass ranged from −9t o2 5H u ,
which revealed a soft tissue. Enhanced CT scanning
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prominent collagenization in the mass (Figure 1).
Firstly, it was clinically considered to be an irreducible
hernia. Then, a myxoid liposarcoma was considered to
be the best preoperative diagnosis after combined with
physical examination and radiographic outcomes. Sur-
gical treatment was performed in August 2012. Rapid
intraoperative pathological diagnosis revealed a benign
mesenchymal tissue neoplasm and the complete local
excision was carried out. Macroscopically, the excised
tumor was 24.0 ×10.5 ×5.0 cm in size, soft and well-
circumscribed by a thin fibrous capsule. The cut surface
was yellow-gray and mucoid (Figure 2). Histologically,
the tumors was mainly composed by a proliferation of
small spindle or stellate cells variably admixed with
mature adipose tissue embedded within an abundant
myxoid and collagenized stroma. The spindle cells had a
small hyperchromatic nuclei in which pleomorphism,
atypia, or mitotic activity were extremely rare (Figures 3
and 4). Immunohistochemical staining revealed that the
spindle and stellate cells stained strongly positive for
vimentin, CD34, and bcl-2 antibodies, Stains for smooth
muscle actin and desmin were negative (Figures 5, 6 and 7).
The patient’s postoperative course was unremarkable. No
evidence of the local recurrence or metastasis has been
seen in the 9 months since excision.
Discussion
Dendritic fibromyxolipoma is an uncommon benign soft
tissue tumor that first reported by Suster et al. in 1998 in
twelve patients [1]. Since then, only four cases of DFML,
including ours, have been reported in the English literature
and cited in Pub Med (Table 1). The mass more commonly
arises in the subcutaneous tissue of subcutis or muscular
fascia of the head and neck, shoulders, chest wall or
back, and predominantly affects male adults. Although
uncommon, there are still cases of DFML reported in
the intramuscular and in the median nerve. Clinical
follow-up in all available cases showed no evidence of
recurrence or metastasis after surgical treatment [2-4].
The most striking histologic feature of DFML is an
admixture of mature adipose tissue, spindle and stellate
cells, and abundant myxoid stroma with prominent
collagenization. Immunohistochemically, the vimentin
and CD34 immunohistochemical stains accentuated the
cell’s dendritic nature by revealing slender, complex cyto-
plasmic prolongations which are the main reason of it’s
named [1]. The curative treatment for DFML is completely
local excision. Recurrence or metastasis has never been
reported in DFML patients after surgical treatment.
DFML should be differentiated from some benign
lesions: spindle cell lipoma (SCL), solitary fibrous
tumor(SFT), lipoblastoma, lipoblastomatosis, and nodular
Figure 1 Computed tomography scan showed the tumor was located in the subcutis, well-demarcated, and isolated from the
abdominal cavity.
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likely to be confused with DFML. SCL is composed of
a mixture of mature adipocytes and uniform spindle
cells within a matrix of mucinous material traversed by
a varying number of birefringent collagen fibers. It
shares many features with DFML including age, male
predilection, location, gross features. The signally similar
clinical and histological feature of the lesions makes it diffi-
cult for distinguishing DFML from SCL [5]. Suster et al.
emphasized the dendritic nature of the spindle cells, the
plexiform vascular pattern, and the abundance of keloidal
collagen as the three essential features in DFML, which
were not commonly presented in SCL [1]. But recently
studies revealed that some features, such as prominent
vascular patterns, and short bipolar cytoplasmic exten-
sions, also had been seen in SCL [2].
Other benign spindle cell tumor that should be distin-
guished from DFML is solitary fibrous tumor (SFT). SFTs
which have a predilection for the thoracic cavity are rare fi-
brous neoplasms. Histologically, the tumor is characterized
by a “patternless pattern” of short spindle cells with scant
cytoplasm and bland cytologic appearance separated by
strands of rope-like collagen, and a “hemangiopericytoma-
like” pattern where the lesional cells are densest around
small and medium ectatic and branching vessels [6]. The
“hemangiopericytoma-like” vascular pattern and the lack of
an adipose tissue component are two histologically features
for distinguishing SFT from DFML [2]. Lipoblastoma and
lipoblastomatosis are another two rare benign soft tissue
mesenchymal tumours that may be confused with DFML.
Figure 3 Histologic features of the lesion showed the tumor was composed by small spindle cells, variably admixed with mature
adipose tissue, embedded within an abundant myxoid (HE 100×).
Figure 2 Gross appearance of the tumor. The tumor was soft and
well-circumscribed by a thin fibrous capsule.
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and children under the age of 3 years. The common
microscopic features of lipoblastoma and lipoblastomatosis
have been described as a mixture composed of immature
lipoblasts,mature lipocytes,embedded in an abundant my-
xoid stroma. DFML could be easily distinguished from
lipoblastoma and lipoblastomatosis by the patients age and
the absence of lipoblasts [1,7]. Nodular fascitis is another
lesion that should be differentiated from DFML. Nodular
fascitis shows proliferating spindle cells embedded in a
loosely textured myxoid and inflammatory stroma. Unlike
DFML, the lesion is relatively well circumscribed but poor
encapsulated. Immunohistochemically, the spindle cells are
positive for muscle markers except desmin and are S-100
protein and CD-34 negative [8].
The distinction between DFML and malignancy, both
of which can have a plentiful myxoid matrix, proliferation
of capillaries and relatively large size, is more subtle and
difficult. Among the malignant tumors, the possibility
of a myxoid liposarcoma (MLS) should be seriously consid-
ered. MLS, a low grade malignancies, is the most common
subtype of liposarcoma. MLS shares many features with
DFML including a delicate plexiform vascular pattern,
large size, and a myxoid matrix. But MLS is distinguished
Figure 5 Strong immunoreactivity for CD34 (100×).
Figure 4 Higher magnification showing spindle and stellate cells with thin, dendritic cytoplasmic prolongations (HE 400×).
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lection, the infiltration of surrounding structures, and
the presence of lipoblasts on higher magnification [1,9].
Furthermore, molecular studies had shown that MLS was
characterized by the recurrent translocations t(12;16)
(q13;p11) and, less commonly, t(12;22)(q13;q12), which
fuse FUS or EWSR1, respectively, to DDIT3 on chromo-
some 12 gene [10]. Narendra et al. confirmed that FISH
with DDIT 3 break-apart probe was a valuable adjunct
in diagnosis or differential diagnosis of MLS [11].
DFML has never been described in the perineum
region. DFML in the perineum region of females should
be differentiated from perianal sepsis, lesions of anogeni-
tal mammary-like glands (AGMLG) and some relatively
site-specific stromal tumours. Perianal abscess/sepsis is
the most common cause of a mass in the perineum region
Figure 7 Strong immunoreactivity for vimentin (100×).
Figure 6 Strong immunoreactivity for bcl-2 (100×).
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ical presentation [12]. AGMLG are a newly recognized
variant of cutaneous adnexal glands that are found in
the anogenital area of both sexes, with characteristics
of modified eccrine and apocrine glands. Lesions of
AGMLG such as hidroadenoma papilliferum, apocrine
cystadenoma, adenosis tumor, and extramammary
Paget's diasease, show a typically striking homology
with lesions in the breast. Histologically, the appear-
ance of glandular structures and the histological hom-
ology to its counterpart breast lesions, helps distinguish
lesions of AGMLG from DFML [13]. Some stromal
tumours, including angiomyofibroblastoma, aggressive
angiomyxoma, cellular angiofibroma, leiomyosarcoma,
rhabdomyosarcoma and epithelioid sarcoma, can also
be found in the perineum region [14,15]. Of these,
angiomyofibroblastoma, aggressive angiomyxoma,
leiomyosarcoma, rhabdomyosarcoma and epithelioid
sarcoma can be easily distinguished from DFML by
their histopathological and immunohistochemical
findings. The distinction between DFML and cellular
angiofibroma, both of which can have adipocytes in
addition to the characteristic vascular network and
connective tissue stroma, is more subtle and difficult.
However, cellular angiofibroma lacks the dendritic
processes and prominent myxoid component of DFML.
In addition, the striking hyalinization of the blood
vessel walls in cellular angiofibroma is another distinct-
i v ef e a t u r en o tf o u n di nD F M L[ 2 , 1 6 ] .
Even though DFML has been found for more than
14 years, the nosological position of DFML is still
indeterminate. Suster et al. [1] initially stressed that
DFML represented a transitional form between SCL
and SFT. But recently studies by Fritchie et al. [17]
on the molecular relationship with SCL and SFT had
found that only SCL showed monoallelic or biallelic
loss of 13q14(RB1), revealed that SCL had not
relationship with SFT. Karim et al. [2] thought that
DFML probably represents an peculiarly variant of
myxoid SCL, based on their similarly clinical and
pathological features.
Conclusion
Dendritic fibromyxolipoma is very rare benign tumor.
We report the first example of DFML in the right
inguinal and perineum region. A diagnosis of DFML
should be made by their microscopical and immunohis-
tochemical features. DFML should be considered in the
differenial diagnosis of lesions with spindle cell lipoma,
solitary fibrous tumor, lipoblastoma, lipoblastomatosis,
nodular fasciitis, and myxoid liposarcoma.
Table 1 Clinical findings of DFML in the 15 patients reported in the Einglish literature
Reference Year Sex/Age Location size (cm) Clinical follow-up Immunohistochemical
Suster [1] 1998 M/33 11-cm mass in left posterior shoulder
acromium region
INA CD34+, BCL-2+
M/58 7.5×5.5× 3.0cm, right shoulder NED, 7 year CD34+, BCL-2+
M/54 5.0× 5.0×4.0cm, right posterior neck INA CD34+, BCL-2+
M/63 6.0×5.5× 2.0cm, upper back INA CD34+, BCL-2+
M/66 8.0 ×3.5×2.5cm, back of the neck INA CD34+, BCL-2+
M/66 9.0× 7.0×6.5cm, back, posterior
axillary fold
INA CD34+, BCL-2+
M/70 2.0× 2.0×2.0cm, face right nasal area NED, 11 year CD34+, BCL-2+
M/73 7.0× 5.5×2.5cm, right posterior neck NED, 13 year CD34+, BCL-2+
M/77 3.0×2.0× 1.5cm, back of neck NED, 5 year CD34+, BCL-2+
M/79 3.5 ×3.0×2.5cm, right chest wall Died of meta static Carcinoma of giant cell
carcinoma of the Lung 2 year after surgery
CD34+, BCL-2+
M/81 3.5×3.0× 3.0cm, left chest wall,
infraclavicula
NED, 5 year CD34+, BCL-2+
F/50 6.0×5.5× 5.0cm, right upper back INA CD34+, BCL-2+
Karim [2] 2003 M/73 13.0×8.0× 5.5cm, between the
infraspinatus and deltoid muscles
NED, 8 mouths CD34+, BCL-2 +
Dahlin [3] 2012 F/65 The median nerve in the left forearm INA CD34+, BCL-2 +
Al-Maskery [4] 2011 F/36 2.0×2.0× 2.0cm NED, 2 years CD34+, CD-99+
in the lower lip BCL-2 +
M, male; F, female; INA, information not available; NED, no evidence of recurrence.
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